Dehydroepiandrosterone (DHEA): hypes and hopes. (Q38229306)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25022952%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Dehydroepiandrosterone (DHEA): hypes and hopes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25022952%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25022952%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Anna Kuryliszyn-Moskal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25022952%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Krzysztof Rutkowski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25022952%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Joanna Rutkowska-Talipska

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25022952%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Ryszard Rutkowski

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25022952%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

1 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25022952%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25022952%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25022952%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25022952%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

1195-1207

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25022952%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s40265-014-0259-8

9 March 2020

exact match

0 references

cites work

An abbreviated account of some aspects of the biochemistry of DHEA, 1934-1995.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

DHEAS as a new diagnostic tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Beneficial effect of dehydroepiandrosterone on pulmonary hypertension in a rodent model of pulmonary hypertension in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Role of DHEA in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

The biological actions of dehydroepiandrosterone involves multiple receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Dehydroepiandrosterone (DHEA)--a precursor steroid or an active hormone in human physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Nongenomic bronchodilating action elicited by dehydroepiandrosterone (DHEA) in a guinea pig asthma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Dehydroepiandrosterone, the endothelium, and cardiovascular protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Synthesis and application of a photoaffinity analog of dehydroepiandrosterone (DHEA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Evaluation of a novel photoactive and biotinylated dehydroepiandrosterone analog

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

DHEA and DHEA-S: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Clinical uses and misuses of dehydroepiandrosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

DHEA(S)--a novel marker in Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Dehydroepiandrosterone in therapy of allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Dehydroepiandrosterone: Is There a Role for Replacement?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Consensus Document on substitution therapy with DHEA in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

DHEA therapy for women: effect on sexual function and wellbeing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

DHEA as a miracle drug in the treatment of poor responders; hype or hope?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Liquid chromatography-tandem mass spectrometry assay for androstenedione, dehydroepiandrosterone, and testosterone with pediatric and adult reference intervals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Age Changes and Sex Differences in Serum Dehydroepiandrosterone Sulfate Concentrations throughout Adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Biomarkers of caloric restriction may predict longevity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

DHEA treatment: myth or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Long-term exposure to dehydroepiandrosterone affects the transcriptional activity of the glucocorticoid receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Two years of treatment with dehydroepiandrosterone does not improve insulin secretion, insulin action, or postprandial glucose turnover in elderly men or women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Long-term DHEA substitution in female adrenocortical failure, body composition, muscle function, and bone metabolism: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Replacement of DHEA in aging men and women. Potential remedial effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Dehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Effects of topical DHEA on aging skin: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Skin responses to topical dehydroepiandrosterone: implications in antiageing treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Modulation of collagen metabolism by the topical application of dehydroepiandrosterone to human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Dehydroepiandrosterone replacement in women with adrenal insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Dehydroepiandrosterone replacement in patients with Addison's disease has a bimodal effect on regulatory (CD4+CD25hi and CD4+FoxP3+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Patients with refractory Crohn's disease or ulcerative colitis respond to dehydroepiandrosterone: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Inhibition of vascular inflammation by dehydroepiandrosterone sulfate in human aortic endothelial cells: roles of PPARalpha and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-{beta}/NFAT axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Effects of combined bacille Calmette-Guérin and dehydroepiandrosterone treatment on established asthma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Dehydroepiandrosterone suppresses eosinophil infiltration and airway hyperresponsiveness via modulation of chemokines and Th2 cytokines in ovalbumin-sensitized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Effects of dehydroepiandrosterone on Th2 cytokine production in peripheral blood mononuclear cells from asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Understanding asthma using animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

DHEA-S inhibits human neutrophil and human airway smooth muscle migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Nebulized dehydroepiandrosterone-3-sulfate improves asthma control in the moderate-to-severe asthma results of a 6-week, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Effect of dehydroepiandrosterone on atopic dermatitis-like skin lesions induced by 1-chloro-2,4-dinitrobenzene in mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Serum concentration of dehydroepiandrosterone sulphate in female patients with chronic idiopathic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Decline in dehydroepiandrosterone sulfate observed in chronic urticaria is associated with psychological distress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Plasma concentration of interleukin 6 (IL-6), and its relationship with circulating concentration of dehydroepiandrosterone sulfate (DHEA-S) in patients with chronic idiopathic urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Prolactin and dehydroepiandrosterone sulfate: are they related to the severity of chronic urticaria?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Dehydroepiandrosterone Antagonizes the Suppressive Effects of Dexamethasone on Lymphocyte Proliferation*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

The effects of dexamethasone and dehydroepiandrosterone (DHEA) on cytokines and receptor expression in a human osteoblastic cell line: potential steroid-sparing role for DHEA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Opposing effects of cortisol and dehydroepiandrosterone on the expression of the receptor for Activated C Kinase 1: implications in immunosenescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Asthma and dehydroepiandrosterone (DHEA): facts and hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

The future of chronic obstructive pulmonary disease treatment--difficulties of and barriers to drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

The patents on glucocorticosteroids and selected new therapies for the management of asthma in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Serum dehydroepiandrosterone sulfate concentration as an indicator of adrenocortical suppression during inhaled steroid therapy in adult asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Clinical review: DHEA replacement for postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Dehydroepiandrosterone supplementation in elderly men: a meta-analysis study of placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Therapy of endocrine disease: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

DHEA supplementation may improve IVF outcome in poor responders: a proposed mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Administration of DHEA augments progesterone production in a woman with low ovarian reserve being transplanted with cryopreserved ovarian tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0259-8

Liquid chromatographic determination of dehydroepiandrosterone (DHEA) in dietary supplement products

21 January 2018

1 reference

12 December 2020

Dehydroepiandrosterone - is the fountain of youth drying out?

1 reference

12 December 2020

Lower serum concentration of dehydroepiandrosterone sulphate in patients suffering from chronic idiopathic urticaria

1 reference

12 December 2020

Dehydroepiandrosterone (DHEA) and Aging. Proceedings of a conference. Washington, D.C., June 17-19, 1995

1 reference

12 December 2020

Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells

1 reference

12 December 2020

Dehydroepiandrosterone (DHEA): a fountain of youth?

1 reference

12 December 2020

Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.

1 reference

12 December 2020

Photo-DHEA--a functional photoreactive dehydroepiandrosterone (DHEA) analog

1 reference

12 December 2020

Dehydroepiandrosterone may be one of the regulators of cytokine production in atopic dermatitis

1 reference

12 December 2020

DHEA supplementation: the claims in perspective

1 reference

12 December 2020

DHEA supplementation positively affects spontaneous pregnancies in women with diminished ovarian function

1 reference

12 December 2020

Attenuation of house dust mite Dermatophagoides farinae-induced airway allergic responses in mice by dehydroepiandrosterone is correlated with down-regulation of TH2 response

1 reference

12 December 2020